Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ridvan Orkut

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biotechnology and Applied Biochemistry|December 3, 2024
Cell line development and bioreactor process optimization for an atezolizumab biosimilarAyca Zeybek Kuyucu, Dogu Sayili, Ridvan Orkut, et al.
Microbial Biotechnology|January 16, 2025
Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastorisSibel Kalyoncu, Dogu Sayili, Ayca Zeybek Kuyucu, et al.
Journal of Extracellular Vesicles|March 26, 2026
Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against LeishmaniasisIsmail Cem Yilmaz, Ibrahim Tokmak, Muzaffer Yildirim, et al.
Scientific Reports|March 30, 2023
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastorisSibel Kalyoncu, Semiramis Yilmaz, Ayca Zeybek Kuyucu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biotechnology and Applied Biochemistry|December 3, 2024
Cell line development and bioreactor process optimization for an atezolizumab biosimilarAyca Zeybek Kuyucu, Dogu Sayili, Ridvan Orkut, et al.
Microbial Biotechnology|January 16, 2025
Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastorisSibel Kalyoncu, Dogu Sayili, Ayca Zeybek Kuyucu, et al.
Journal of Extracellular Vesicles|March 26, 2026
Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against LeishmaniasisIsmail Cem Yilmaz, Ibrahim Tokmak, Muzaffer Yildirim, et al.
Scientific Reports|March 30, 2023
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastorisSibel Kalyoncu, Semiramis Yilmaz, Ayca Zeybek Kuyucu, et al.
Pageof 1